Second Annual Global Champions of Change Competition Winner

MMS has just concluded its second annual Global Champions of Change Competition (G3C), where colleagues from all MMS regions submitted innovative ideas based on our tradition of providing high-quality, efficient services to our clients to help discover and market life-changing medicines to patients around the world.  

Innovation is not new to MMS, we have designed our culture from the beginning to constantly strive for new and better ways to produce quality with efficiency. The G3C competition was created two years ago as a formal way to spark the sharing of innovative ideas from colleagues throughout the entire organization in a competitive but fun environment.  

This year’s G3C winner is Amanda Beaster, Senior Manager of Regulatory Strategy, for her submission of a tool to address labeling deficiencies in the pharmaceutical industry.  

The second-place winners are Audelia Munguia, Director of Safety Risk Management; Susan Mitcheson, Senior Safety Writer; Jeff Wiese, Technical Manager of Safety Writing; and Katrina O’Connor, Senior Medical Writer, for their submission aimed to enhance efficiencies and quality in aggregate reports.  

Thirty-one teams entered this year’s competition, and five teams were chosen to proceed to the final presentation round, with our global colleagues voting for the winner. All 31 entries are evaluated and considered for future implementation.  

Other submissions included ideas that included automation, improving processes, data visualization, supporting rare diseases, improving quality, and concepts relating to MMS technologies such as our TrialAssure Transparency Suite and Datacise.  

MMS believes that innovation comes directly from our colleagues at every level of the organization because those working in our services lines daily see the best opportunities for improvement, and are encouraged to bring those ideas forward. That’s why we often say that “innovation is a company sport”. The G3C competition is not the only time our colleagues can bring innovative ideas forward, and MMS colleagues are encouraged to submit their ideas for improvement throughout the year.   

We are so proud of our colleagues and the effort, energy, and excitement they exhibited during this competition and through their work on a daily basis.  

By Jim Balcom, Director of Partnerships and IT Governance 

Learn more and explore MMS career opportunities here.  

Contact us to speak with Jim Balcom to learn more about innovation.  

Suggested For You

perspectives

July 30th, 2024

The Critical Role of Quality Control (QC) – Medical Writing and Beyond

perspectives

July 23rd, 2024

PSI 2024 Ignited Conversations on External Data Sources, Requirements for Estimands, and Bayesian Methodology for Statisticians in Pharma

perspectives

July 16th, 2024

Key Steps to Successful CMC Authoring of IND and IMPD Submissions

perspectives

July 9th, 2024

Managing RTOR Submissions: How to Run a Successful Race from the Top Line Starting Line

perspectives

July 2nd, 2024

Part 1: RWD Noninterventional Study Design and FDA Engagement Opportunity for Early Stage Oncology

perspectives

June 21st, 2024

Peer-Reviewed Journal Articles: The Crucial Role of Publication in the Pharmaceutical Industry

perspectives

June 14th, 2024

A Structured Approach to Benefit-Risk Assessment Throughout Product Development in the Pharmaceutical Industry

perspectives

June 6th, 2024

Datacise and Diversity in Patient Enrollment: Combining Geospatial and Demographic Data to Aid Site Selection

perspectives

May 29th, 2024

Confined Deferrals in Clinical Trial Applications: Anticipating the Revised EU CTR Transparency Rules

perspectives

May 21st, 2024

Psychedelics and Regulatory Considerations Part II: A Shift in Lexicon and Implications of “Nonmedical Use” On Labelling

perspectives

May 10th, 2024

Psychedelics in Drug Development and Regulatory Considerations Part I: Benefit-Risk

perspectives

April 29th, 2024

Validation of Clinical Dashboards for Decision Making